Sales & Marketing
Minutes to answers: Compliant chat builds more meaningful HCP relationships
As therapies become more complex, field reps and doctors are finding …
19700 items found
News
Lilly says tirzepatide supply issues are resolving
Eli Lilly has raised its revenue guidance for 2024 by $3 billion, …
News
AI biotechs Exscientia and Recursion agree $688m merger
In one of the biggest M&A deals involving artificial …
Sales & Marketing
You’re trusted less than a waiter and more than a pilot, but why?
Sobering results from a YouGov poll across the UK show that …
News
Novartis gets FDA OK for first in its trio of IgAN therapies
Novartis has claimed accelerated approval from the FDA for a second …
Sales & Marketing
Could the way you work be inhibiting digital success?
Pharma companies are investing a lot of money in digital products, …
News
UK drive for research, trial subjects hits key milestone
More than half a million people in the UK have signed up to …
R&D
The growing challenge of conducting clinical trials for metabolic associated steatohepatitis (MASH)
Liver disease is on the rise around the world, posing a significant …
News
After a no in sickle cell, NICE OKs Casgevy for thalassaemia
Vertex and CRISPR Therapeutics have won the backing of NICE for their …
News
Does Roche have buyer's remorse for Flatiron takeover?
Roche is reported to be considering the sale of its cancer data …
News
Wegovy slowdown rattles Novo Nordisk investors
Shares in Novo Nordisk have gone into reverse after it reported …
R&D
Partner Content
2nd Cell Therapy for Autoimmune Disease Summit | Download the BRAND-NEW Program
The 2nd Cell Therapy for Autoimmune Disease Summit returns to …
News
Novo Nordisk closes on EU okay for haemophilia antibody
Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
